Safety and efficacy of concurrent cisplatin and radiotherapy in inoperable or metastatic squamous cell esophageal cancer

Acta Oncologica

Volumn 41, Issue 5, 2002, Pages 457-462

  Kumar, Shaleen ^a   Dimri, Kislay ^a   Datta, Niloy R ^a   Rastogi, Neeraj ^a   Lal, Punita ^a   Das, Koilpillai J Maria ^a   Ayyagari, Sundar ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CHEMOTHERAPY; RADIOTHERAPY; TUMORS;

SWALLOWING STATUS;

ONCOLOGY;

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; FLUOROURACIL; MANNITOL; MITOMYCIN C;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; ESOPHAGUS CANCER; ESOPHAGUS METASTASIS; FEMALE; HUMAN; INOPERABLE CANCER; LEUKOPENIA; MALE; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; SWALLOWING; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DEGLUTITION DISORDERS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; RADIOISOTOPE TELETHERAPY; SAFETY; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; VOMITING;

EID: 0036406615     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418602320405050     Document Type: Article

References (20)

1. Herskovic A, Martz K, Sarraf MA, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
2. Slabber CF, Nel JS, Schoeman L, Burger W, Falkson G, Falkson CI. A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol 1998; 21: 462-5.
3. Hall EJ. Radiobiology for the Radiologist. 4th Ed. Philadelphia: JB Lippincott Co, 1994: 212-29.
4. Fowler JF. The linear-quadratic model and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679-94.
5. Wilson GD, McNally NJ, Dische S. Measurements of cell kinetics in human tumor in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 1988; 58: 423-31.
6. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 3: 1341-6.
7. Sakai K. Inakoshi H, Sueyama H, et al. Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1995; 31: 921-7.
8. Chan A, Wong A, Arthur K. Concomitant 5-fluorouracil infusion, mitomycin C and radical radiation therapy in esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1989; 16: 59-65.
9. Smith TJ, Ryan LM, Douglass HO, et al. Combined chemoradiotherapy vs radiotherapy alone for early stage squamous cell carcinoma of the esophagus. A study of the ECOG. Int J Radiat Oncol Biol Phys 1998; 42: 269-76.
10. Seitz JF, Giovannini M, Cesana JP, et al. Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer 1990; 66: 214-9.
11. Minsky BD, Neuberg D, Kelsen DP, Pisansky TM, Ginsberg R, Benson A. Neoadjuvant chemotherapy plus concurrent chemotherapy and high dose radiation for squamous cell carcinoma of the esophagus: A preliminary analysis of the phase II Intergroup trial 0122. J Clin Oncol 1996; 14: 149-55.
12. Hejna M, Kornek GV, Sehn AUS, et al. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma. Cancer 1996; 78: 1646-50.
13. Aisner J, Forastiere A, Aroney R. Patterns of recurrence for cancer of lung and esophagus. In: Wittes RE, ed. Cancer Treatment Symposia: Proc Workshop on Patterns of Failure After Cancer Treatment. Washington DC. US Department of Health and Human Services 1983; 2: 87.
14. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long term results of infusional 5-FU, mitomycin C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1990; 20: 29-36.
15. Araujo CMM, Souhami L, Gil RA, et al. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991; 67: 2258-61.
16. Urba SG, Turrisi III AT. Split course accelerated radiation therapy combined with carboplatin and 5-fluorouracil for palliation of metastatic or unresectable carcinoma of the esophagus. Cancer 1995; 75: 435-9.
17. Gaspar LE, Qian C, Kocha WI, Coia LR, Herskovic A, Graham M. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): Preliminary toxicity report. Int J Radiat Oncol Biol Phys 1997; 37: 593-9.
18. Poplin EA, Jacobson J, Herskovic A, et al. Evaluation of multimodality treatment of loco-regional esophageal carcinoma by the Southwest Oncology Group 9060. Cancer 1996; 78: 1851-6.
19. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer. Long term follow-up of a prospective randomized trial (RTOG 85-01) JAMA 1999; 281: 1623-7.
20. Minsky BD, Neuberg D, Kelsen DP, et al. Final report of Intergroup trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1999; 43: 517-23.